GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » Gross Profit

China Healthwise Holdings (HKSE:00348) Gross Profit : HK$60.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings Gross Profit?

China Healthwise Holdings's gross profit for the six months ended in Dec. 2023 was HK$26.6 Mil. China Healthwise Holdings's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was HK$60.3 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. China Healthwise Holdings's gross profit for the six months ended in Dec. 2023 was HK$26.6 Mil. China Healthwise Holdings's Revenue for the six months ended in Dec. 2023 was HK$65.5 Mil. Therefore, China Healthwise Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 40.68%.

China Healthwise Holdings had a gross margin of 40.68% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of China Healthwise Holdings was 53.50%. The lowest was 6.94%. And the median was 33.62%.


China Healthwise Holdings Gross Profit Historical Data

The historical data trend for China Healthwise Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings Gross Profit Chart

China Healthwise Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 164.73 61.06 90.99 53.27 60.29

China Healthwise Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.50 26.53 26.74 33.65 26.64

Competitive Comparison of China Healthwise Holdings's Gross Profit

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Healthwise Holdings's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's Gross Profit falls into.



China Healthwise Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

China Healthwise Holdings's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=146.317 - 86.023
=60.3

China Healthwise Holdings's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=65.491 - 38.85
=26.6

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$60.3 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

China Healthwise Holdings's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=26.6 / 65.491
=40.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


China Healthwise Holdings  (HKSE:00348) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

China Healthwise Holdings had a gross margin of 40.68% for the quarter that ended in Dec. 2023 => Durable competitive advantage


China Healthwise Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


China Healthwise Holdings (HKSE:00348) Business Description

Traded in Other Exchanges
N/A
Address
168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Executives
Eternity Investment Limited 2201 Interest of corporation controlled by you
Heng Tai Consumables Group Limited 2201 Interest of corporation controlled by you
Heng Tai Finance Limited 2101 Beneficial owner
Lei Hong Wai 2101 Beneficial owner

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines